Shanghai - Delayed Quote CNY

Joinn Laboratories(China)Co.,Ltd. (603127.SS)

19.52
-0.31
(-1.56%)
At close: 3:00:02 PM GMT+8
Loading Chart for 603127.SS
  • Previous Close 19.83
  • Open 19.66
  • Bid 19.52 x --
  • Ask 19.53 x --
  • Day's Range 19.31 - 19.81
  • 52 Week Range 12.32 - 23.48
  • Volume 27,378,914
  • Avg. Volume 23,429,590
  • Market Cap (intraday) 13.979B
  • Beta (5Y Monthly) 0.69
  • PE Ratio (TTM) 38.27
  • EPS (TTM) 0.51
  • Earnings Date Aug 28, 2025 - Sep 1, 2025
  • Forward Dividend & Yield 0.16 (0.81%)
  • Ex-Dividend Date Jul 31, 2024
  • 1y Target Est --

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.

www.joinn-lab.com

2,652

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 603127.SS

View More

Performance Overview: 603127.SS

Trailing total returns as of 6/11/2025, which may include dividends or other distributions. Benchmark is 000001.SS (000001.SS) .

YTD Return

603127.SS
17.38%
000001.SS (000001.SS)
1.51%

1-Year Return

603127.SS
34.52%
000001.SS (000001.SS)
12.36%

3-Year Return

603127.SS
67.12%
000001.SS (000001.SS)
3.58%

5-Year Return

603127.SS
37.44%
000001.SS (000001.SS)
16.48%

Compare To: 603127.SS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 603127.SS

View More

Valuation Measures

Annual
As of 6/10/2025
  • Market Cap

    14.20B

  • Enterprise Value

    12.08B

  • Trailing P/E

    38.88

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.58

  • Price/Book (mrq)

    1.83

  • Enterprise Value/Revenue

    6.10

  • Enterprise Value/EBITDA

    27.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    19.56%

  • Return on Assets (ttm)

    0.46%

  • Return on Equity (ttm)

    4.77%

  • Revenue (ttm)

    1.98B

  • Net Income Avi to Common (ttm)

    387.42M

  • Diluted EPS (ttm)

    0.51

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.17B

  • Total Debt/Equity (mrq)

    0.65%

  • Levered Free Cash Flow (ttm)

    296.69M

Research Analysis: 603127.SS

View More

Company Insights: 603127.SS

Research Reports: 603127.SS

View More

People Also Watch